Sunrest LifescienceNSE:SUNREST 41 Operating Margin % is 16.97% as of Mar. 2026, which is 297% above its 10-year median of 4.27. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Sunrest Lifescience ranks better than 86.23% on this metric.
Sunrest Lifescience Ltd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Sunrest Lifescience's Operating Margin % or its related term are showing as below:
NSE:SUNREST'
s Operating Margin % Range Over the Past 10 Years
Min: 1.42 Med: 4.27 Max: 16.97
Current: 16.97
NSE:SUNREST's Operating Margin % is ranked better than 86.23% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs NSE:SUNREST: 16.97
Sunrest Lifescience's 5-Year Average Operating Margin % Growth Rate was 39.00% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Sunrest Lifescience Operating Margin % Related Terms
Sunrest Lifescience Operating Margin % Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Sunrest Lifescience's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience (NSE:SUNREST) has a Operating Margin % of 16.97% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Sunrest Lifescience and its competitors. This is 297% above median its historical median of 4.27. Over the past decade, Sunrest Lifescience's Operating Margin % has ranged from 1.42 to 16.97. According to the industry distribution chart, Sunrest Lifescience ranks #92 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 13.8%.
Is Sunrest Lifescience's Operating Margin % too high?
Sunrest Lifescience's current Operating Margin % of 16.97% is 297% above median its 10-year median of 4.27. Over the past 10 years, this metric has ranged from a low of 1.42 to a high of 16.97. The Healthcare Providers & Services industry median Operating Margin % is 4.85. Sunrest Lifescience's value of 16.97% is 250.3% above this industry median. Based on the distribution chart, Sunrest Lifescience ranks #92 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Operating Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #92 out of 668 companies for Operating Margin %. This places Sunrest Lifescience in the top 14% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 4.85. Sunrest Lifescience's value of 16.97% is 250.3% above this benchmark. Historically, Sunrest Lifescience's own Operating Margin % has ranged from 1.42 to 16.97 over the past decade. While the company's 10-year median is 4.27 vs. the industry median of 4.85, Sunrest Lifescience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current Operating Margin % of 16.97% is 250.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current Operating Margin % is 16.97%, which is 297% above median its own 10-year median of 4.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Operating Margin % of 16.97%. The current Operating Margin % is 16.97%, which is 297% above median its 10-year median of 4.27 and 250.3% above the Healthcare Providers & Services industry median of 4.85. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Operating Margin % is 16.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score
Get the complete analysis for NSE:SUNREST
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
